70.18
price down icon4.65%   -3.42
pre-market  Pre-market:  71.15   0.97   +1.38%
loading
Lantheus Holdings Inc stock is traded at $70.18, with a volume of 1.35M. It is down -4.65% in the last 24 hours and down -11.15% over the past month. Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
See More
Previous Close:
$73.60
Open:
$74.47
24h Volume:
1.35M
Relative Volume:
1.17
Market Cap:
$4.86B
Revenue:
$1.50B
Net Income/Loss:
$427.61M
P/E Ratio:
11.68
EPS:
6.01
Net Cash Flow:
$423.98M
1W Performance:
-13.69%
1M Performance:
-11.15%
6M Performance:
-23.28%
1Y Performance:
-39.36%
1-Day Range:
Value
$69.88
$74.47
1-Week Range:
Value
$69.12
$83.32
52-Week Range:
Value
$69.12
$118.71

Lantheus Holdings Inc Stock (LNTH) Company Profile

Name
Name
Lantheus Holdings Inc
Name
Phone
978 671-8001
Name
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Name
Employee
808
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
LNTH's Discussions on Twitter

Compare LNTH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
LNTH
Lantheus Holdings Inc
70.18 5.63B 1.50B 427.61M 423.98M 6.01
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
148.60 68.99B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.43 46.36B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.60 44.74B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.06 18.81B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
292.01 13.33B 2.99B 1.21B 1.13B 25.06

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-18-24 Initiated Goldman Buy
Sep-03-24 Initiated Redburn Atlantic Buy
Jul-10-24 Reiterated JMP Securities Mkt Outperform
Dec-18-23 Downgrade William Blair Outperform → Mkt Perform
Dec-04-23 Initiated TD Cowen Outperform
Sep-29-23 Initiated William Blair Outperform
Mar-08-23 Initiated JMP Securities Mkt Outperform
Nov-30-22 Initiated SVB Leerink Outperform
Oct-13-22 Initiated Mizuho Buy
May-09-22 Initiated B. Riley Securities Buy
Apr-13-22 Initiated Truist Buy
Feb-01-21 Initiated SVB Leerink Outperform
Jun-29-20 Resumed Jefferies Buy
Aug-16-19 Upgrade CJS Securities Market Perform → Market Outperform
Nov-02-17 Upgrade Wells Fargo Market Perform → Outperform
Nov-08-16 Reiterated RBC Capital Mkts Outperform
Sep-23-16 Resumed Credit Suisse Neutral
Feb-24-16 Reiterated RBC Capital Mkts Outperform
Dec-11-15 Downgrade Credit Suisse Outperform → Neutral
Sep-30-15 Downgrade Wells Fargo Outperform → Market Perform
Jul-20-15 Initiated Credit Suisse Outperform
Jul-20-15 Initiated Jefferies Buy
Jul-20-15 Initiated RBC Capital Mkts Outperform
Jul-20-15 Initiated Robert W. Baird Outperform
Jul-20-15 Initiated Wells Fargo Outperform
View All

Lantheus Holdings Inc Stock (LNTH) Latest News

pulisher
Jul 20, 2025

Lantheus Holdings Inc. Stock Analysis and ForecastFree Stock Market Forecast Reports - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Lantheus Holdings Inc. stock priceHigh-yield market plays - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Lantheus Holdings Inc. stockFree Trading Strategy Suggestions - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is Lantheus Holdings Inc. a good long term investmentOutstanding investment returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Lantheus (LNTH): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Lantheus sinks 8% as CMS wants to maintain reimbursement model for radiopharmaceuticals - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

Learn to Evaluate (LNTH) using the Charts - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 16, 2025

Radiopharmaceutical Renaissance: Lantheus Navigates CMS Policy Shifts to Secure Dominance in Diagnostic Imaging - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Lantheus Holdings (LNTH) Plunges 14.94% Amid CMS Decision - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Lantheus Holdings (LNTH) Stock Falls as CMS Retains Current Reim - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

Why Is Lantheus Stock Trading Lower On Wednesday? - Benzinga

Jul 16, 2025
pulisher
Jul 16, 2025

Why Lantheus (LNTH) Stock Is Down Today - TradingView

Jul 16, 2025
pulisher
Jul 16, 2025

Lantheus (LNTH) Shares Decline Amid Market Activity | LNTH Stock News - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

Lantheus Plummets to 52-Week Low: Is the Bottom in Sight or More Pain Ahead? - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Lantheus Holdings stock reaches 52-week low at $72.92 By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Lantheus Holdings stock reaches 52-week low at $72.92 - Investing.com

Jul 16, 2025
pulisher
Jul 16, 2025

Lantheus (LNTH) Likely to Maintain Pylarify Reimbursement Status in 2026 | LNTH Stock News - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

Lantheus (LNTH) Faces Setback with CMS Reimbursement Decision | - GuruFocus

Jul 16, 2025
pulisher
Jul 15, 2025

Lantheus set to close $750M acquisition of PET agent developer Life Molecular Imaging - Radiology Business

Jul 15, 2025
pulisher
Jul 11, 2025

Lantheus Holdings: Navigating Geopolitical Storms to Capture Precision Diagnostics Growth - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know - Yahoo Finance

Jul 11, 2025
pulisher
Jul 06, 2025

(LNTH) Investment Report - news.stocktradersdaily.com

Jul 06, 2025
pulisher
Jul 06, 2025

Lantheus Holdings’ SWOT analysis: theranostics leader faces growth challenges - Investing.com

Jul 06, 2025
pulisher
Jul 06, 2025

Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2025 Earnings Call Transcript - MSN

Jul 06, 2025
pulisher
Jul 02, 2025

Lantheus’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

Jul 02, 2025
pulisher
Jul 01, 2025

Could The Market Be Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH) Given Its Attractive Financial Prospects? - 富途牛牛

Jul 01, 2025
pulisher
Jun 29, 2025

Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment - MSN

Jun 29, 2025
pulisher
Jun 29, 2025

Riley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT - Insider Monkey

Jun 29, 2025
pulisher
Jun 28, 2025

Lantheus Holdings (LNTH): A Breakthrough in Fibrosis Imaging and a Compelling Investment Thesis - AInvest

Jun 28, 2025
pulisher
Jun 27, 2025

Lantheus to Present New Oncology Radiodiagnostic Data at SNMMI Meeting - MSN

Jun 27, 2025
pulisher
Jun 23, 2025

Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & SuppliesImaging, Diagnostics Stocks In Q1 - Yahoo Finance

Jun 23, 2025
pulisher
Jun 17, 2025

Alzheimer’s Association Partners with Lantheus for 30th Annual Charity Golf Tournament - The Bedford Citizen

Jun 17, 2025
pulisher
Jun 17, 2025

Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path - Investing.com Nigeria

Jun 17, 2025
pulisher
Jun 17, 2025

Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 15, 2025

(LNTH) Technical Data - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 15, 2025

The total return for Lantheus Holdings (NASDAQ:LNTH) investors has risen faster than earnings growth over the last five years - simplywall.st

Jun 15, 2025
pulisher
Jun 12, 2025

Lantheus Announces Presentations to be featured at the 2025 Soci - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Insider Sell: Julie Mchugh Sells Shares of Lantheus Holdings Inc (LNTH) - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Lantheus Holdings, Inc. to Present New Data on Oncology Radiodiagnostics at 2025 SNMMI Annual Meeting - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and ... - Eagle-Tribune

Jun 11, 2025
pulisher
Jun 11, 2025

Lantheus Unveils Breakthrough Cancer Diagnostic Results at SNMMI 2025: Multiple Studies Show Promise - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

Lantheus at Goldman Sachs Conference: Strategic Expansion in Healthcare By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Lantheus at Goldman Sachs Conference: Strategic Expansion in Healthcare - Investing.com

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Lantheus Holdings, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Lantheus to Present at the 2025 Truist Securities MedTech Conference - The Manila Times

Jun 10, 2025
pulisher
Jun 10, 2025

Lantheus CEO Reveals Growth Strategy: Key Insights Coming at Truist MedTech Conference - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Declining Stock and Solid Fundamentals: Is The Market Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH)? - Yahoo Finance

Jun 10, 2025
pulisher
Jun 07, 2025

Investor Network: Lantheus Holdings Inc. to Host Earnings Call - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 05, 2025

Investor Network: Lantheus Holdings Inc to Host Earnings Call - ACCESS Newswire

Jun 05, 2025

Lantheus Holdings Inc Stock (LNTH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$14.78
price down icon 1.20%
$8.88
price down icon 4.21%
drug_manufacturers_specialty_generic RDY
$14.48
price down icon 1.43%
$132.02
price down icon 1.56%
$292.01
price down icon 1.79%
Cap:     |  Volume (24h):